多发性骨髓瘤中的血小板过度活化在意义未明的单克隆丙种球蛋白病中也可见到
本研究采用流式细胞术多参数分析MGUS、冒烟型骨髓瘤/多发性骨髓瘤患者及健康对照的血小板活化与反应性。MGUS患者血小板表面CD63、annexin V及PAC-1结合中位数显著高于健康对照,SM/MM患者亦升高但未达显著;74%的MGUS和38%的SM/MM患者至少一项活化标志物升高,健康对照为19%。
要点
- MGUS患者血小板表面CD63、annexin V和PAC-1结合中位数显著高于健康对照。
- 74%的MGUS和38%的SM/MM患者至少一项血小板活化标志物升高,健康对照为19%。
- MGUS患者血小板对ADP刺激后P-选择素表面水平显著降低,提示反应性低下。
核心结论
- 血小板过度活化在MGUS和SM/MM患者中均常见,且可能与反应性低下相关。
- 作者认为有必要进一步研究血小板过度活化在这类患者中的预测和预后价值。
研究设计与样本
- 研究采用流式细胞术对MGUS、SM/MM患者及健康对照进行血小板活化与反应性的多参数分析。
主要发现
- MGUS患者血小板表面CD63、annexin V和PAC-1抗体结合的中位数显著高于健康对照。
- SM/MM患者上述标志物亦升高,但未达统计学显著。
- 74%的MGUS和38%的SM/MM患者至少一项血小板活化标志物升高,健康对照为19%。
- 体外观察到血小板对激动剂[二磷酸腺苷(ADP)、凝血酶受体激活肽6]刺激的标志物特异性反应性低下,MGUS患者对ADP刺激后P-选择素表面水平显著降低。
- 患者血小板-白细胞聚集体未见改变,部分患者血小板相关免疫球蛋白升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombotic events are common in patients with multiple myeloma (MM), smouldering myeloma (SM) and monoclonal gammopathy of undetermined significance (MGUS). Previous studies have indicated platelet hyperactivation as a feature of thrombotic risk in MM, but there is a dearth of data in MGUS. In the present study, multiparameter analysis of platelet activation and responsiveness was investigated by flow cytometry in patients with MGUS, SM/MM and healthy controls (HCs). The median platelet surface CD63 levels, annexin V and PAC-1 antibody (specific for activated integrin αIIbβ3) binding were significantly elevated in patients with MGUS versus the HCs. These markers were also elevated in SM/MM, but not significantly. In all, 74% of MGUS and 38% of SM/MM patients had one or more elevated marker of platelet activation, compared to 19% of the HCs. Marker-specific hyporesponsiveness of platelets to agonist [adenosine diphosphate (ADP), thrombin receptor-activating peptide 6] stimulation in vitro was observed, with significantly reduced surface levels of P-selectin in response to ADP in patients with MGUS. Platelet-leucocyte aggregates were not altered in patients, while platelet-associated immunoglobulins were elevated in a subset of patients. Overall, we found that platelet hyperactivation is prevalent in both MGUS and SM/MM patients and is potentially related to hyporesponsiveness. These observations suggest that further investigation of the predictive and prognostic value of platelet hyperactivation in such patients is warranted.
引用
- O'Sullivan LR, Meade-Murphy G, Gilligan OM, et al. Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance. Br J Haematol. 2020. PMID: 32478420. doi:10.1111/bjh.16774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。